Karki revealed that ADAR1 could interact with the Zα2 domain of ZBP1 to inhibit the combinations between ZBP1 and RIPK3, resulting in the inhibition of ZBP1-mediated PANoptosis and promotion of tumorigenesis in CRC [62]. Here, ZBP1 is linked to colorectal carcinoma.